Published Technical Disclosure Archive

Expanding Diarylalkanes' Potential: Novel Applications and Use Cases

Publication ID: 24-11857657_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanding Diarylalkanes' Potential: Novel Applications and Use Cases,” Published Technical Disclosure No. 24-11857657_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857657_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,657.

Summary of the Inventive Concept

This inventive concept leverages the core technology of diarylalkanes as potent inhibitors of binuclear enzymes to tackle diverse industrial, environmental, and agricultural challenges, unlocking new opportunities for process optimization, pollution mitigation, and crop enhancement.

Background and Problem Solved

The original patent focused on diarylalkanes' potential in treating skin pigmentation and related conditions. However, the limitations of this narrow application scope have been overcome by exploring the technology's broader implications. This inventive concept addresses the need for innovative solutions in various industries, where binuclear enzyme activity is a critical factor.

Detailed Description of the Inventive Concept

The new claims introduce diarylalkane-based sensors for industrial process monitoring, diarylalkane compounds for optimizing fuel cell performance, and diarylalkane-based coatings for preventing biofilm formation on medical devices. Additionally, the technology can be applied to treating water pollution and improving crop yields. These novel applications capitalize on the diarylalkanes' ability to inhibit binuclear enzyme activity, offering a versatile platform for addressing complex problems.

Novelty and Inventive Step

The new claims depart from the original patent's focus on skin pigmentation, introducing a paradigm shift in the application of diarylalkanes. The inventive step lies in recognizing the technology's broader potential and adapting it to tackle diverse, high-impact challenges.

Alternative Embodiments and Variations

Alternative embodiments could include diarylalkane-based biosensors for real-time monitoring, integration with IoT systems for remote process control, or development of diarylalkane-conjugated nanoparticles for targeted delivery in agricultural or environmental applications.

Potential Commercial Applications and Market

This inventive concept has far-reaching commercial potential, with applications in industries such as industrial process control, renewable energy, water treatment, medical devices, and agriculture. The target market includes companies seeking innovative solutions for process optimization, pollution mitigation, and crop enhancement, as well as research institutions exploring new applications for diarylalkanes.

CPC Classifications

SectionClassGroup
A A61 A61K8/347
A A61 A61K8/31
A A61 A61K8/4973
A A61 A61K8/9789
A A61 A61K8/9794
A A61 A61K31/015
A A61 A61K31/05
A A61 A61K31/085
A A61 A61K31/09
A A61 A61K31/357
A A61 A61K31/40
A A61 A61K31/704
A A61 A61Q19/02
C C07 C07C39/15
C C07 C07C39/367
C C07 C07C41/26
C C07 C07C41/32
C C07 C07C43/23
C C07 C07C45/673
C C07 C07C49/835
C C07 C07C215/74
C C07 C07D321/12
A A61 A61K2800/782
Y Y02 Y02A50/30

Field of Art

Biochemical engineering and pharmaceutical sciences, with expertise in enzyme inhibition, molecular interactions, and biotechnological applications involving binuclear enzyme systems

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degree in biochemistry or chemical engineering, experienced in enzyme mechanisms, molecular design, and interdisciplinary technology transfer, capable of recognizing structural analogies and potential alternative applications of enzyme inhibition technologies

Obviousness Rationale

A PHOSITA would recognize that the fundamental mechanism of binuclear enzyme inhibition disclosed in the source patent provides a versatile platform for exploring diverse technological applications. The core principle of targeting enzyme activity through diarylalkane compounds naturally suggests potential extensions across industrial, environmental, and biological domains. Given the known structure-function relationships of these compounds, a skilled practitioner would find it straightforward to adapt the technology for sensing, process control, and targeted intervention strategies.

Obvious Combinations & Variations

Source Patent Element
Diarylalkane compounds capable of inhibiting binuclear enzyme activity
PTD Variation
Developing diarylalkane-based sensors for industrial process monitoring
Obviousness Reasoning
Predictable extension of known enzyme inhibition mechanism to create detection and control systems, utilizing the compound's inherent molecular interaction capabilities
Source Patent Element
Skin pigmentation treatment through enzyme inhibition
PTD Variation
Agricultural applications for improving crop yields by inhibiting specific enzymatic processes
Obviousness Reasoning
Known technique of leveraging enzyme modulation across biological systems, representing a logical and foreseeable technological transfer
Source Patent Element
Neutralization of active oxygen species in skin treatment
PTD Variation
Water pollution treatment by inhibiting enzymatic processes in aquatic microorganisms
Obviousness Reasoning
Finite set of identifiable solutions for applying enzyme inhibition technology to environmental remediation challenges
Source Patent Element
Molecular interactions targeting specific enzymatic pathways
PTD Variation
Biofilm prevention on medical devices through enzyme activity disruption
Obviousness Reasoning
Predictable application of known molecular interaction principles to solve related technological problems
Source Patent Element
Diarylalkane compounds with specific structural characteristics
PTD Variation
Fuel cell performance optimization through enzyme activity modulation
Obviousness Reasoning
Design choice representing standard engineering problem-solving approach using known molecular interaction principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857657, a person of ordinary skill in the art would find the variations disclosed herein obvious and anticipated, as they represent straightforward technological extensions of the fundamental enzyme inhibition mechanism disclosed in the source patent. The claimed variations emerge from standard engineering problem-solving techniques and do not represent non-obvious innovations beyond the scope of ordinary technological development.

Original Patent Information

Patent NumberUS 11,857,657
TitleDiarylalkanes as potent inhibitors of binuclear enzymes
Assignee(s)Unigen, Inc.